Flecainide acetate and Ovarian cancer - a phase IV clinical study of FDA data
No or too few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or too few reports are found.
What is Flecainide Acetate?
Flecainide acetate has active ingredients of flecainide acetate. It is used in atrial fibrillation/flutter. Currently, eHealthMe is studying from 6,781 Flecainide acetate users.
What is Ovarian Cancer?
Ovarian cancer (cancer of ovary) is found to be associated with 1,196 drugs and 704 conditions by eHealthMe. Currently, we are studying 61,697 people who have Ovarian cancer.
Do you take Flecainide acetate and have Ovarian cancer?Check whether Ovarian cancer is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Ovarian cancer and when was it recovered:
Expand to all the drugs that have ingredients of flecainide acetate:
Alternative drugs to, pros and cons of Flecainide acetate:
- Flecainide acetate (6,781 reports)
Browse all side effects of Flecainide acetate:a b c d e f g h i j k l m n o p q r s t u v w x y z
Ovarian cancer treatments and more:
- Ovarian cancer (61,697 reports)
All the drugs that are associated with Ovarian cancer:
All the conditions that are associated with Ovarian cancer:
How the study uses the data?
The study uses data from the FDA. It is based on flecainide acetate (the active ingredients of Flecainide acetate) and Flecainide acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Penicillin and Lidocaine drug interaction - a second ago
- Ms Contin and Stable Angina - 15 seconds ago
- Bextra and Stent - 17 seconds ago
- Exjade and Ejection Fraction Decreased - 20 seconds ago
- Tadalafil and Cholestasis - 21 seconds ago
- Lotrimin and Neuropathy Peripheral - 23 seconds ago
- Amicar and Renal Failure Chronic - 23 seconds ago
- Gemcitabine and Neuropathy Peripheral - 34 seconds ago
- Glyburide and Oedema Upper Limb - 43 seconds ago
- Fragmin and Non-Hodgkin'S Lymphoma - 45 seconds ago